Compounds That Target CDK13

cyclin dependent kinase 13 · 19 compounds in BiohacksAI corpus

CDK13 (cyclin dependent kinase 13) is a protein kinase involved in intracellular signal transduction. Kinases phosphorylate downstream substrates to regulate cell growth, survival, and metabolism. The 19 compounds targeting CDK13 include both pharmaceutical inhibitors and natural compounds with evidence of kinase modulation, ranked by evidence strength from the BiohacksAI corpus.

View CDK13 target page →UniProt: Q14004 ↗

Most Studied Compounds for CDK13

Ha1077

11+

studies

All 19 Compounds — Ranked by Evidence

Alvocidib

4.52

confidence

Foretinib

4.34

confidence

Doramapimod

4.06

confidence

Dinaciclib

3.87

confidence

Fasudil

3.66

confidence

Bms 387032

3.47

confidence

Linifanib

3.33

confidence

At 7519

3.33

confidence

Lestaurtinib

3.04

confidence

Defosbarasertib

2.89

confidence

Pf 00562271

2.77

confidence

Bms 345541

2.71

confidence

Ast 487

2.56

confidence

Defactinib

2.48

confidence

Rg 547

2.08

confidence

Amg 900

2.08

confidence

Ravoxertinib

2.08

confidence

Istisociclib

2.08

confidence

Ha1077

11+

studies

0.69

confidence

The compounds above were identified through computational analysis of BindingDB binding assay data and PubMed literature for CDK13 (cyclin dependent kinase 13). Confidence scores reflect the strength and breadth of experimental evidence.

Explore related resources: CDK13 target overview · All biological targets · Biological pathways

Data from BindingDB and PubMed. For research purposes only. Not medical advice.